BBOT— BridgeBio Oncology Therapeutics, Inc. Stock Signals & AI Analysis
67
AI Conviction Score1
Signals (30d)
67
Avg Score
No Active Convergence
No multi-source convergence detected for BBOT in the last 7 days
BBOT Signal Activity (30 days)
Insider Trades
0
8-K Filings
1
See full 8-k filings...
Congress Trades
0
BBOT 8-K Material Events
11 SEC 8-K filing detected — bankruptcies, mergers, auditor changes, and more
Get full BBOT analysis free
See complete insider trade details, AI analysis, convergence breakdowns, options flow data, and real-time alerts. No credit card required.
Sign Up FreeFree tier includes delayed signals, Live Feed, and community Discord access
Frequently Asked Questions About BBOT
Are insiders buying BBOT stock?
No recent insider purchases detected in the last 30 days for BridgeBio Oncology Therapeutics, Inc. (BBOT). Open Alpha monitors all SEC Form 4 filings in real-time and will alert when insiders at BridgeBio Oncology Therapeutics, Inc. buy or sell shares.
What do congressional trades say about BBOT?
No recent congressional trading activity detected for BridgeBio Oncology Therapeutics, Inc. (BBOT). Open Alpha monitors congressional trade disclosures from both the House and Senate. Note that congressional trades are reported with a 28-45 day delay by law.
Is there unusual dark pool activity on BBOT?
Open Alpha monitors FINRA Reg SHO daily short volume data for BridgeBio Oncology Therapeutics, Inc. (BBOT) and thousands of other tickers. Dark pool short volume ratios above historical averages can indicate institutional positioning. Sign up free to access dark pool monitoring and threshold list alerts for BBOT.
What is the AI conviction score for BBOT?
The highest recent AI conviction score for BridgeBio Oncology Therapeutics, Inc. (BBOT) is 67/100, with an average score of 67/100 across 1 signals in the last 30 days. Open Alpha's convergence engine combines insider trades, options flow, congressional activity, and SEC filings to generate conviction scores from 0-100.
How accurate are trading signals for BBOT?
Not enough tracked outcomes are available yet to calculate a reliable win rate for BridgeBio Oncology Therapeutics, Inc. (BBOT). Open Alpha tracks all signal outcomes over 7-day, 14-day, and 30-day horizons using verified Tiingo price data. As more signals fire and resolve, accuracy statistics will become available. This is not investment advice.